Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Human–yeast chimeric repair protein protects mammalian cells against alkylating agents: enhancement of MGMT protection

Cancer Gene Therapy volume 10, pages 603–610 (2003)Cite this article

Abstract

Chemotherapeutic DNA alkylating agents are common weapons employed to fight both pediatric and adult cancers. In addition to cancerous cells, nontarget tissues are subjected to the cytotoxicity of these agents, and dose-limiting toxicity in the form of myelosuppression is a frequent result of treatment. One approach to prevent myelosuppression that results from the use of chemotherapeutic agents is to increase the levels of DNA repair proteins in bone marrow cells. Here we report our second successful attempt to create a fusion protein that possesses both direct reversal and base excision repair pathway DNA repair activities. The chimeric protein is composed of the human O6-Methylguanine-DNA Methyltransferase (MGMT) and the yeast Apn1 proteins and retains both MGMT and AP endonuclease activities as determined by biochemical analysis. We have also demonstrated that the chimeric protein is able to protect mammalian cells from the DNA alkylating agents 1,3-bis (2-chloroethyl)-1-nitrosourea (BCNU) and methyl methanesulfonate (MMS). The protection by the chimeric protein against BCNU is even greater than MGMT alone, which has potential translational significance given that MGMT is currently in clinical trials. Additionally, we show that the chimeric MGMT-Apn1 protein can protect mammalian cells from dual treatments of BCNU and MMS and that this effect is greater than that provided by MGMT alone. The data support our previous finding that a protein with multiple DNA repair activities can be constructed and that this and other constructs may play an important clinical role in guarding against dose-limiting effects of chemotherapy, particularly in situations of multiple drug use.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3

Similar content being viewed by others

References

  1. Hansen WK, Kelley MR . Review of mammalian DNA repair and translational implications. J Pharmacol Exp Ther. 2000;295:1–9.

    CAS  PubMed  Google Scholar 

  2. Wadhwa PD, Zielske SP, Roth JC, Ballas CB, Bowman JE, Gerson SL . Cancer gene therapy: scientific basis. Annu Rev Med. 2002;53:437–452.

    Article  CAS  Google Scholar 

  3. Hansen WK, Deutsch WA, Yacoub A, Xu Y, Williams DA, Kelley MR . Creation of a fully functional human chimeric DNA repair protein. Combining O6-methylguanine DNA methyltransferase (MGMT) and AP endonuclease (APE/redox effector factor 1 (Ref 1)) DNA repair proteins. J Biol Chem. 1998;273:756–762.

    Article  CAS  Google Scholar 

  4. Limp-Foster M, Kelley MR . DNA repair and gene therapy: implications for translational uses. Environ Mol Mutagen. 2000;35:71–81.

    Article  CAS  Google Scholar 

  5. Jelinek J, Rafferty J, Cmejla R, et al. A novel dual function retrovirus expressing multidrug resistance 1 and O6-alkylguanine-DNA-alkyltransferase for engineering resistance of haemopoietic progenitor cells to multiple chemotherapeutic agents. Gene Ther. 1999;6:1489–1493.

    Article  CAS  Google Scholar 

  6. Frosina G . Overexpression of enzymes that repair endogenous damage to DNA. Eur J Biochem. 2000;267:2135–2149.

    Article  CAS  Google Scholar 

  7. Friedberg EC, Walker GC, Siede W . DNA Repair and Mutagenesis. Washington, DC.: ASM Press; 1995.

    Google Scholar 

  8. Gerson SL . Clinical relevance of MGMT in the treatment of cancer. J Clin Oncol. 2002;20:2388–2399.

    Article  CAS  Google Scholar 

  9. Gonzaga PE, Potter PM, Niu TQ, et al. Identification of the cross-link between human O6-methylguanine-DNA methyltransferase and chloroethylnitrosourea-treated DNA. Cancer Res. 1992;52:6052–6058.

    CAS  PubMed  Google Scholar 

  10. Erickson LC, Laurent G, Sharkey NA, Kohn KW . DNA cross-linking and monoadduct repair in nitrosourea-treated human tumour cells. Nature. 1980;288:727–729.

    Article  CAS  Google Scholar 

  11. Robins P, Harris AL, Goldsmith I, Lindahl T . Cross-linking of DNA induced by chloroethylnitrosourea is presented by O6-methylguanine-DNA methyltransferase. Nucleic Acids Res. 1983;11:7743–7758.

    Article  CAS  Google Scholar 

  12. Samson L, Derfler B, Waldstein EA . Suppression of human DNA alkylation-repair defects by Escherichia coli DNA-repair genes. Genetics. 1986;83:5607–5610.

    CAS  Google Scholar 

  13. He YH, Wu M, Kobune M, Xu Y, Kelley MR, Martin WJ . Expression of yeast apurinic/apyrimidinic endonuclease (APN1) protects lung epithelial cells from bleomycin toxicity. Am J Respir Cell Mol Biol. 2001;25:692–698.

    Article  CAS  Google Scholar 

  14. Ramotar D . The apurinic–apyrimidinic endonuclease IV family of DNA repair enzymes. Biochem Cell Biol. 1997;75:327–336.

    Article  CAS  Google Scholar 

  15. Bregni M, Magni M, Siena S, Di Nicola M, Bonadonna G, Gianni AM . Human peripheral blood hematopoietic progenitors are optimal targets of retroviral-mediated gene transfer. Blood. 1992;80:1418–1422.

    CAS  PubMed  Google Scholar 

  16. Bodine DM, Moritz T, Donahue RE, et al. Long-term in vivo expression of a murine adenosine deaminase gene in rhesus monkey hematopoietic cells of multiple lineages after retroviral mediated gene transfer into CD34+bone marrow cells. Blood. 1993;82:1975–1980.

    CAS  PubMed  Google Scholar 

  17. Moritz T, Williams DA . Transfer of drug resistance genes to hematopoietic precursors. In: Bertino, J. R. ed. Encyclopedia of Cancer, Vol. III. San Diego: Academic Press; 1997: 1765–1776.

    Google Scholar 

  18. Dirven HA, Dictus EL, Broeders NL, van Ommen B, van Bladeren PJ . The role of human glutathione S-transferase isoenzymes in the formation of glutathione conjugates of the alkylating cytostatic drug thiotepa. Cancer Res. 1995;55: 1701–1706.

    CAS  PubMed  Google Scholar 

  19. Rekha GK, Sreetama L, Sladek NE . Intrinsic cellular resistance to oxazaphosphorines exhibited by a human colon carcinoma cell line expressing relatively large amounts of a class-3 aldehyde dehydrogenase. Biochem Pharmacol. 1994;48:1943–1952.

    Article  CAS  Google Scholar 

  20. Ueda K, Cardarelli C, Gottesman MM, Pastan I . Expression of a full-length cDNA for the human “MDR1” gene confers resistance to colchicine, doxorubicin, and vinblastine. Proc Natl Acad Sci USA. 1987;84:3004–3008.

    Article  CAS  Google Scholar 

  21. Wang J, Chen Z, Xia X, Lu D, Xue J, Ruan C . Improvement of combination chemotherapy tolerance by introduction of polycistronic retroviral vector drug resistance genes MGMT and MDR1 into human umbilical cord blood CD34(+) cells. Leuk Res. 2002;26:281–288.

    Article  Google Scholar 

  22. Suzuki M, Sugimoto Y, Tsuruo T . Efficient protection of cells from the genotoxicity of nitrosoureas by the retrovirus-mediated transfer of human O-6-methylguanine-DNA methyltransferase using bicistronic vectors with human multidrug resistance gene 1. Mutat Res Fundam Mol Mech Mut. 1998;401:133–141.

    Article  CAS  Google Scholar 

  23. Kleibl K, Margison GP . Increasing DNA repair capacity in bone marrow by gene transfer as a prospective tool in cancer therapy. Neoplasma 1998;45:181–186.

    CAS  PubMed  Google Scholar 

  24. Maze R, Kapur R, Kelley MR, Hansen WK, Oh SY, Williams DA . Reversal of 1,3-bis(2-chloroethyl)-1-nitrosourea-induced severe immunodeficiency by transduction of murine long-lived hemopoietic progenitor cells using O6-methylguanine DNA methyltransferase complementary DNA. J Immunol. 1997;158:1006–1013.

    CAS  PubMed  Google Scholar 

  25. Maze R, Kurpad C, Pegg AE, Erickson LC, Williams DA . Retroviral-mediated expression of the P140A, but not P140A/G156A, mutant form of O6-methylguanine DNA methyltransferase protects hematopoietic cells against O6-benzylguanine sensitization to chloroethylnitrosourea treatment. J Pharmacol Exp Ther. 1999;290:1467–1474.

    CAS  PubMed  Google Scholar 

  26. Gerson SL, Miller K, Berger NA . O6 alkylguanine-DNA alkyltransferase activity in human myeloid cells. J Clin Invest. 1985;76:2106–2114.

    Article  CAS  Google Scholar 

  27. Evans AR, Limp-Foster M, Kelley MR . Going APE over ref-1. Mutat Res. 2000;461:83–108.

    Article  CAS  Google Scholar 

  28. Tomicic M, Eschbach E, Kaina B . Expression of yeast but not human apurinic/apyrimidinic endonuclease renders Chinese hamster cells more resistant to DNA damaging agents. Mutat Res. 1997;383:155–165.

    Article  CAS  Google Scholar 

  29. Mol CD, Izumi T, Mitra S, Tainer JA . DNA-bound structures and mutants reveal abasic DNA binding by APE1 and DNA repair coordination [corrected]. Nature. 2000;403:451–456.

    Article  CAS  Google Scholar 

  30. Mol CD, Hosfield DJ, Tainer JA . Abasic site recognition by two apurinic/apyrimidinic endonuclease families in DNA base excision repair: the 3′ ends justify the means. Mutat Res. 2000;460:211–229.

    Article  CAS  Google Scholar 

  31. Tainer JA, Friedberg EC . Dancing with the elephants: envisioning the structural biology of DNA repair pathways. Mutat Res. 2000;460:139–141.

    Article  CAS  Google Scholar 

  32. Daniels DS, Tainer JA . Conserved structural motifs governing the stoichiometric repair of alkylated DNA by O(6)-alkylguanine-DNA alkyltransferase [In Process Citation]. Mutat Res. 2000;460:151–163.

    Article  CAS  Google Scholar 

  33. Kreklau EL, Limp-Foster M, Liu N, Xu Y, Kelley MR, Erickson LC . A novel fluorometric oligonucleotide assay to measure O(6)-methylguanine DNA methyltransferase, methylpurine DNA glycosylase, 8-oxoguanine DNA glycosylase and abasic endonuclease activities: DNA repair status in human breast carcinoma cells overexpressing methylpurine DNA glycosylase. Nucleic Acids Res. 2001;29:2558–2566.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This work was supported by National Institutes of Health grants CA76643, NS38506, ES05865, ES03456, P01-CA75426, and P30 DK49218 supporting MRK, as well as DOD grants OC00113 and OC990085 to MRK. The Riley Memorial Association also supported these studies. We would also like to acknowledge the help of Emi Kreklau for MGMT activity assistance.

Author information

Author notes

  1. Timothy J Roth: Work was performed as partial fulfillment of MS requirements for the Department of Physiology, Indiana University Medical School.

Authors and Affiliations

  1. Department of Physiology and Biophysics, Herman B Wells Center for Pediatric Research, Indiana University School of Medicine, 702 Barnhill Dr, Room 2600, Indianapolis, 46202, Indiana, USA

    Timothy J Roth

  2. Department of Pediatrics (Section of Hematology/Oncology), Biochemistry & Molecular Biology, Pharmacology and Toxicology, Indiana University School of Medicine, Indianapolis, Indiana, USA

    Yi Xu, Meihua Luo & Mark R Kelley

Authors
  1. Timothy J Roth
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yi Xu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Meihua Luo
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Mark R Kelley
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mark R Kelley.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Roth, T., Xu, Y., Luo, M. et al. Human–yeast chimeric repair protein protects mammalian cells against alkylating agents: enhancement of MGMT protection. Cancer Gene Ther 10, 603–610 (2003). https://doi.org/10.1038/sj.cgt.7700605

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.cgt.7700605

Keywords

Search

Advanced search

Quick links